Publications

1. Huang L, Riggan KA, Torbenson VE, Osborne AK, Chesak SS, Finney RE, Allyse MA, Rivera-Chiauzzi EY. Second Victim Experiences of Health Care Learners and the Influence of the Training Environment on Postevent Adaptation. Mayo Clin Proc Innov Qual Outcomes. 2024 Jun; 8 (3):232-240 Epub 2024 Apr 24
   View PubMed
2. Riggan KA, Ormond KE, Allyse MA, Close S. Evidence-based recommendations for delivering the diagnosis of X & Y chromosome multisomies in children, adolescents, and young adults: an integrative review. BMC Pediatr. 2024 Apr 22; 24 (1):263
   View PubMed
3. Artal JM, Randall L, Rubeck S, Allyse M, Michie M, Riggan KA, Meredith S, Skotko BG. Parents of children with Down syndrome reflect on their postnatal diagnoses, 2003-2022. Am J Med Genet A. 2024 Apr 15; e63619 [Epub ahead of print]
   View PubMed
4. Orellana M, DSouza KN, Yap JQ, Sriganeshan A, Jones ME, Johnson C, Allyse M, Venable S, Stewart EA, Enders F, Balls-Berry JE. "In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas. BMC Womens Health. 2024 Apr 12; 24 (1):233
   View PubMed
5. Riggan KA, Barwise A, Yap JQ, Condon N, Allyse MA. Patient experiences with prenatal cell-free DNA screening in a safety net setting. Prenat Diagn. 2024 Apr; 44 (4):409-417 Epub 2024 Feb 29
   View PubMed
6. Ahlawat N, Elliott K, Ormond KE, Allyse MA, Riggan KA. Healthcare and support experiences of adolescents and young adults diagnosed with 47,XXY, 47,XXX, and 48,XXYY. J Community Genet. 2024 Feb; 15 (1):75-83 Epub 2023 Oct 21
   View PubMed
7. James SE, Riggan KA, Halyard M, Kelly M, Cobran E, Allyse MA. The "Strong Black Woman" Paradox: Insights from a Cohort of Black Breast and Ovarian Cancer Patients and Family Members. J Racial Ethn Health Disparities. 2024 Jan 8 Epub 2024 Jan 08
   View PubMed
8. Rivera-Chiauzzi EY, Huang L, Osborne AK, Musch AA, Berkland BE, Meyer AT, Vitek SM, Wieneke KC, Allyse MA, Riggan KA, Finney RE. Rapid Expansion of the Healing Emotional Lives of Peers Program During COVID-19: A Second Victim Peer Support Program for Healthcare Professionals. J Patient Saf. 2024 Jan 1; 20 (1):28-37 Epub 2023 Nov 16
   View PubMed
9. Huang L, Huschka TR, Barwise AK, Allen JP, Wolfersteig W, Hamm K, Cardenas LD, Phelan SM, Allyse MA. Psychological reactance, misinformation, and distrust: A mixed methods analysis of COVID-19 vaccine uptake. J Clin Transl Sci. 2024; 8 (1):e48 Epub 2024 Jan 30
   View PubMed
10. Riggan KA, Weaver AL, Ashby G, Huang L, Long ME, Torbenson VE, Wick MJ, Allyse MA, Rivera-Chiauzzi EY. Influence of the COVID-19 pandemic on prenatal and postpartum patient experiences and well-being. Birth. 2023 Dec; 50 (4):1034-1044 Epub 2023 Aug 09
    View PubMed
11. Rousseau A, Riggan KA, Halyard M, James SE, Kelly M, Phillips D, Allyse MA. Cancer Screening Experiences of Black Breast and Ovarian Cancer Patients and Family Members. J Community Health. 2023 Oct; 48 (5):882-888 Epub 2023 May 23
    View PubMed
12. Nissim NR, Fudge MR, Lachner C, Babulal GM, Allyse MA, Graff-Radford NR, Lucas JA, Day GS. Age-Specific Barriers and Facilitators to Research Participation Amongst African Americans in Observational Studies of Memory and Aging. J Racial Ethn Health Disparities. 2023 Aug 9 Epub 2023 Aug 09
    View PubMed
13. Riggan KA, Rousseau AC, DSouza KN, Woodward KT, Lue J, Phelan SM, Allyse MA, Shenoy CC. Patient perceptions of body mass index restrictions limiting fertility care for women with high body mass index. Reprod Biomed Online. 2023 Aug; 47 (2):103210 Epub 2023 Apr 09
    View PubMed
14. Craig KP, Riggan KA, Rubeck S, Meredith SH, Allyse MA, Michie M. Never "totally prepared": Support groups on helping families prepare for a child with a genetic condition. J Community Genet. 2023 Jun; 14 (3):319-327 Epub 2023 Apr 12
    View PubMed
15. Batbold S, Cummings G, Riggan KA, Michie M, Allyse M. Views of parents of children with Down syndrome on Alzheimer's disease vaccination. J Intellect Disabil. 2023 May 24; 17446295231177787 [Epub ahead of print]
    View PubMed
16. Barwise AK, Egginton J, Pacheco-Spann L, Clift K, Albertie M, Johnson M, Batbold S, Phelan S, Allyse M. Community engaged research to measure the impact of COVID-19 on vulnerable community member's well-being and health : A mixed methods approach. Wien Klin Wochenschr. 2023 May; 135 (9-10):221-227 Epub 2022 Dec 05
    View PubMed
17. Riggan KA, Rousseau A, Halyard M, James SE, Kelly M, Phillips D, Allyse MA. "There's not enough studies": Views of black breast and ovarian cancer patients on research participation. Cancer Med. 2023 Apr; 12 (7):8767-8776 Epub 2023 Jan 16
    View PubMed
18. Barwise A, Huschka T, Woo C, Egginton J, Huang L, Allen JS, Johnson M, Hamm K, Wolfersteig W, Phelan S, Allyse M. Perceptions and Use of Telehealth Among Diverse Communities: Multisite Community-Engaged Mixed Methods Study. J Med Internet Res. 2023 Mar 28; 25:e44242
    View PubMed
19. Abu Dabrh AM, Haga CB, Conrad J, Perlman AI, Allyse MA, Albertie ML, Martinez-Heath M, Ball CT, Willis FB. Nutrition and Emotional Health Education: The Use of Emotional Intelligence and a Plant-Based Diet to Reduce Cardiometabolic Risk. Glob Adv Integr Med Health. 2023 Jan-Dec; 12:27536130231215014 Epub 2023 Nov 17
    View PubMed
20. Richardson JP, Ahlawat N, Riggan KA, Close S, Allyse MA. Experiences of individuals receiving a sex chromosome multisomy diagnosis. J Community Genet. 2022 Dec; 13 (6):619-628 Epub 2022 Aug 19
    View PubMed
21. Riggan KA, Gross B, Close S, Steinberg A, Allyse MA. "Knowledge is Power": Parent Views on the Benefits of Early Diagnosis and Awareness of Sex Chromosome Multisomy Among Pediatric Professionals. J Dev Behav Pediatr. 2022 Nov 30 [Epub ahead of print]
    View PubMed
22. Huang L, Riggan KA, Ashby GB, Rivera-Chiauzzi EY, Allyse MA. Pregnant and Postpartum Patients' Views of COVID-19 Vaccination. J Community Health. 2022 Oct; 47 (5):871-878 Epub 2022 July 16
    View PubMed
23. DeStephano CC, Allyse MA, Abu Dabrh AMM, Ridgeway JL, Salinas M, Sherman ME, Spaulding AC. Pilot study of women's perspectives when abnormal uterine bleeding occurs during perimenopause. Climacteric. 2022 Oct; 25(5):510-515. Epub 2022 Jun 02.
    View PubMed
24. Orellana M, Riggan KA, DSouza K, Stewart EA, Venable S, Balls-Berry JE, Allyse MA. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids. J Racial Ethn Health Disparities. 2022 Aug; 9 (4):1184-1191 Epub 2021 May 19
    View PubMed
25. Allyse MA, Michie M. Prenatal genetics in a post-Roe United States. Cell Rep Med. 2022 Jul 19; 3 (7):100690 Epub 2022 July 05
    View PubMed
26. Ashby GB, Riggan KA, Huang L, Torbenson VE, Long ME, Wick MJ, Allyse MA, Rivera-Chiauzzi EY. "I had so many life-changing decisions I had to make without support": a qualitative analysis of women's pregnant and postpartum experiences during the COVID-19 pandemic. BMC Pregnancy Childbirth. 2022 Jul 4; 22 (1):537 Epub 2022 July 04
    View PubMed
27. Rousseau AC, Riggan KA, Schenone MH, Whitford KJ, Pittock ST, Allyse MA. Ethical considerations of maternal-fetal surgery. J Perinat Med. 2022 Jun 27; 50 (5):519-527 Epub 2022 Jan 31
    View PubMed
28. Rivera-Chiauzzi E, Finney RE, Riggan KA, Weaver AL, Long ME, Torbenson VE, Allyse MA. Understanding the Second Victim Experience Among Multidisciplinary Providers in Obstetrics and Gynecology. J Patient Saf. 2022 Mar 1; 18 (2):e463-e469
    View PubMed
29. DSouza KN, Orellana M, Ainsworth AJ, Cummings G, Riggan KA, Shenoy CC, Allyse MA. Impact of the COVID-19 Pandemic on Patient Fertility Care. J Patient Exp. 2022; 9:23743735221098255 Epub 2022 May 06
    View PubMed
30. Huang L, Cleveland T, Clift K, Egginton JS, Pacheco-Spann L, Johnson MG, Albertie M, Cardenas LD, Phelan SM, Allyse MA, Barwise AK. Key Stakeholder Perspectives of Community Engagement Efforts and the Impact of the Covid-19 Pandemic. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319221133076
    View PubMed
31. Reckhow J, Riggan KA, Allyse MA, Long M, Torbenson V, Rivera-Chiauzzi EY. Impact of the COVID-19 Pandemic on Obstetricians/Gynecologists. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec; 5 (6):1128-1137 Epub 2021 Nov 10
    View PubMed
32. Finney RE, Czinski S, Fjerstad K, Arteaga GM, Weaver AL, Riggan KA, Allyse MA, Long ME, Torbenson VE, Rivera-Chiauzzi EY. Evaluation of a Second Victim Peer Support Program on Perceptions of Second Victim Experiences and Supportive Resources in Pediatric Clinical Specialties Using the Second Victim Experience and Support Tool (SVEST). J Pediatr Nurs. 2021 Nov-Dec; 61:312-317 Epub 2021 Sept 06
    View PubMed
33. Riggan KA, Gross B, Close S, Weinberg A, Allyse MA. Prenatal Genetic Diagnosis of a Sex Chromosome Aneuploidy: Parent Experiences. J Genet Couns. 2021 Oct; 30(5):1407-1417. Epub 2021 Mar 15.
    View PubMed
34. Finney RE, Torbenson VE, Riggan KA, Weaver AL, Long ME, Allyse MA, Rivera-Chiauzzi EY. Second victim experiences of nurses in obstetrics and gynaecology: A Second Victim Experience and Support Tool Survey. J Nurs Manag. 2021 May; 29 (4):642-652 Epub 2020 Nov 18
    View PubMed
35. Riggan KA, Collura CA, Pittock ST, Ruano R, Whitford KJ, Allyse M. Ethical considerations of maternal-fetal intervention in a twin pregnancy discordant for anomalies. J Matern Fetal Neonatal Med. 2021 Apr; 34 (8):1312-1317 Epub 2019 June 20
    View PubMed
36. Torbenson VE, Riggan KA, Weaver AL, Long ME, Finney RE, Allyse MA, Rivera-Chiauzzi E. Second Victim Experience among OBGYN Trainees: What Is Their Desired Form of Support? South Med J. 2021 Apr; 114 (4):218-222
    View PubMed
37. Richardson JP, Riggan KA, Allyse M. The Expert in the Room: Parental Advocacy for Children with Sex Chromosome Aneuploidies. J Dev Behav Pediatr. 2021 Apr 1; 42 (3):213-219
    View PubMed
38. Orellana M, Valdez-Soto M, Brockman TA, Balls-Berry JE, Zavala Rocha MG, Allyse MA, DSouza KN, Riggan KA, Juhn Y, Patten C. Creating a pediatric advisory board for engaging youth in pediatric health research: A case study. J Clin Transl Sci. 2021 Mar 30; 5 (1):e113
    View PubMed
39. DSouza KN, Orellana M, Riggan KA, Valdez-Soto M, Brockman TA, Zavala Rocha MG, Balls-Berry JE, Juhn Y, Patten CA, Allyse MA. Views and experiences of youth participants in a pediatric advisory board for human subjects research Journal of Clinical and Translational Science. 2021; 5(1):e91.
    
40. Riggan KA, Gilbert A, Allyse MA. Acknowledging and Addressing Allostatic Load in Pregnancy Care. J Racial Ethn Health Disparities. 2021 Feb; 8 (1):69-79 Epub 2020 May 07
    View PubMed
41. Barwise AK, Thorsteinsdottir B, Allyse MA, Clarke MJ, Meagher KM. Bioethics Advocacy in Ethos, Practice and Metrics. Am J Bioeth 2021 Feb; 21 (2):69-72
    View PubMed
42. Enders FT, Golembiewski EH, Pacheco-Spann LM, Allyse M, Mielke MM, Balls-Berry JE. Building a framework for inclusion in health services research: Development of and pre-implementation faculty and staff attitudes toward the Diversity, Equity, and Inclusion (DEI) plan at Mayo Clinic. J Clin Transl Sci. 2021 Jan 5; 5 (1):e88 Epub 2021 Jan 05
    View PubMed
43. Riggan KA, Stewart EA, Balls-Berry JE, Venable S, Allyse MA. Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions. J Patient Exp. 2021; 8:23743735211049655 Epub 2021 Oct 20
    View PubMed
44. Riggan KA, Close S, Allyse MA. Family experiences and attitudes about receiving the diagnosis of sex chromosome aneuploidy in a child. Am J Med Genet C Semin Med Genet. 2020 Jun; 184 (2):404-413 Epub 2020 Mar 17
    View PubMed
45. Gammon BL, Jaramillo C, Riggan KA, Allyse M. Decisional regret in women receiving high risk or inconclusive prenatal cell-free DNA screening results. J Matern Fetal Neonatal Med. 2020 Apr; 33 (8):1412-1418 Epub 2018 Oct 01
    View PubMed
46. Riggan KA, Khan Z, Langstraat CL, Allyse MA. Provider Knowledge and Support of Uterus Transplantation: Surveying Multidisciplinary Team Members. Mayo Clin Proc Innov Qual Outcomes. 2020 Apr; 4 (2):150-158 Epub 2020 Feb 17
    View PubMed
47. Ainsworth AJ, Allyse M, Khan Z. Fertility Preservation for Transgender Individuals: A Review. Mayo Clin Proc. 2020 Apr; 95 (4):784-792 Epub 2020 Feb 27
    View PubMed
48. Meagher KM, Allyse MA, Master Z, Sharp RR. Reexamining the Ethics of Human Germline Editing in the Wake of Scandal. Mayo Clin Proc. 2020 Feb; 95 (2):330-338
    View PubMed
49. Riggan KA, Nyquist C, Michie M, Allyse MA. Evaluating the Risks and Benefits of Genetic and Pharmacologic Interventions for Down Syndrome: Views of Parents. Am J Intellect Dev Disabil. 2020 Jan; 125 (1):1-13
    View PubMed
50. Allyse M, Bombard Y, Isasi R, Michie M, Musunuru K, Ormond KE. What do we do now?: Responding to claims of germline gene editing in humans. Genet Med 2019 Oct; 21 (10):2181-2183 Epub 2019 Mar 27
    View PubMed
51. Skotko BG, Allyse MA, Bajaj K, Best RG, Klugman S, Leach M, Meredith S, Michie M, Stoll K, Gregg AR. Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations. Genet Med. 2019 Oct; 21 (10):2285-2292 Epub 2019 Apr 03
    View PubMed
52. Riggan KA, Sharp RR, Allyse M. Where Will We Draw the Line? Public Opinions of Human Gene Editing. Qual Health Res. 2019 Oct; 29 (12):1823-1835 Epub 2019 May 05
    View PubMed
53. Snure Beckman E, Deuitch N, Michie M, Allyse MA, Riggan KA, Ormond KE. Attitudes Toward Hypothetical Uses of Gene-Editing Technologies in Parents of People with Autosomal Aneuploidies. CRISPR J. 2019 Oct; 2 (5):324-330
    View PubMed
54. Ormond KE, Bombard Y, Bonham VL, Hoffman-Andrews L, Howard H, Isasi R, Musunuru K, Riggan KA, Michie M, Allyse M. The clinical application of gene editing: ethical and social issues. Per Med. 2019 Jul; 16 (4):337-350 Epub 2019 July 23
    View PubMed
55. Riggan KA, Allyse M. 'Compassionate transfer': an alternative option for surplus embryo disposition. Hum Reprod. 2019 May 1; 34 (5):791-794
    View PubMed
56. Jaramillo C, Nyquist C, Riggan KA, Egginton J, Phelan S, Allyse M. Delivering the Diagnosis of Sex Chromosome Aneuploidy: Experiences and Preferences of Parents and Individuals. Clin Pediatr (Phila). 2019 Mar; 58 (3):336-342 Epub 2018 Dec 05
    View PubMed
57. Michie M, Allyse M. Gene modification therapies: views of parents of people with Down syndrome. Genet Med. 2019 Feb; 21 (2):487-492 Epub 2018 June 21
    View PubMed
58. Allyse MA, Wick MJ. Noninvasive Prenatal Genetic Screening Using Cell-free DNA. JAMA. 2018 Aug 14; 320 (6):591-592
    View PubMed
59. Gammon BL, Otto L, Wick M, Borowski K, Allyse M. Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options. J Genet Couns. 2018 Aug; 27 (4):894-901 Epub 2017 Dec 15
    View PubMed
60. Allyse M. CRSPR/CAS 9 and Human Therapeutics. Clin Chem. 2018 Aug 1; 64 (8):1266-1267
    View PubMed
61. Farrell RM, Allyse MA. Key Ethical Issues in Prenatal Genetics: An Overview. Obstet Gynecol Clin North Am. 2018 Mar; 45 (1):127-141 Epub 2017 Dec 09
    View PubMed
62. Allyse MA, Robinson DH, Ferber MJ, Sharp RR. Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing. Mayo Clin Proc. 2018 Jan; 93 (1):113-120
    View PubMed
63. Stoll KA, Mackison A, Allyse MA, Michie M. Conflicts of interest in genetic counseling: acknowledging and accepting. Genet Med 2017 Aug; 19 (8):864-866 Epub 2017 Jan 26
    View PubMed
64. Allyse M, Wick MJ. What do the new American College of Medical Genetics and Genomics (ACMG) guidelines mean for the provision of non-invasive prenatal genetic screening? J Obstet Gynaecol. 2017 Aug; 37 (6):795-798 Epub 2017 Apr 01
    View PubMed
65. Allyse M, Aypar U, Bonhomme N, Darilek S, Dougherty M, Farrell R, Grody W, Highsmith WE, Michie M, Nunes M, Otto L, Pabst R, Palomaki G, Runke C, Sharp RR, Skotko B, Stoll K, Wick M. Offering Prenatal Screening in the Age of Genomic Medicine: A Practical Guide. J Womens Health (Larchmt). 2017 Jul; 26(7):755-761. Epub 2017 Apr 07.
    View PubMed
66. Mozersky J, Ravitsky V, Rapp R, Michie M, Chandrasekharan S, Allyse M. Toward an Ethically Sensitive Implementation of Noninvasive Prenatal Screening in the Global Context. Hastings Cent Rep. 2017 Mar; 47: (2)41-49.
    View PubMed
67. Parham L, Michie M, Allyse M. Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues. Curr Genet Med Rep. 2017 Mar; 5 (1):44-53 Epub 2017 Feb 11
    View PubMed
68. Li G, Chandrasekharan S, Allyse M. "The Top Priority Is a Healthy Baby": Narratives of Health, Disability, and Abortion in Online Pregnancy Forum Discussions in the US and China. J Genet Couns. 2017 Feb; 26 (1):32-39 Epub 2016 June 09
    View PubMed
69. Tilburt JC, Allyse M, Hafferty FW. The Case of Dr. Oz: Ethics, Evidence, and Does Professional Self-Regulation Work? AMA J Ethics. 2017 Feb 01; 19 (2):199-206
    View PubMed
70. Floyd E, Allyse MA, Michie M. Spanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections. J Genet Couns. 2016 Oct; 25 (5):965-77 Epub 2016 Jan 07
    View PubMed
71. Meredith S, Kaposy C, Miller VJ, Allyse M, Chandrasekharan S, Michie M, Prenatal Testing PAG Coalition. Impact of the increased adoption of prenatal cfDNA screening on non-profit patient advocacy organizations in the United States. Prenat Diagn. 2016 Aug; 36(8):714-9. Epub 2016 Jul 18.
    View PubMed
72. Michie M, Kraft SA, Minear MA, Ryan RR, Allyse MA. Informed decision-making about prenatal cfDNA screening: An assessment of written materials. Ethics Med Public Health. 2016 Jul-Sep; 2 (3):362-371 Epub 2016 Sept 13
    View PubMed
73. Gammon BL, Kraft SA, Michie M, Allyse M. "I think we've got too many tests!": Prenatal providers' reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening. Ethics Med Public Health. 2016 Jul-Sep; 2 (3):334-342
    View PubMed
74. Li G., Allyse M. Experiences of Mandarin-speaking and English-speaking women of undergoing non-invasive prenatal genetic screening. Ethics, Medicine and Public Health.2016;2:(3):372-82.
    
75. Steinbach RJ, Allyse M, Michie M, Liu EY, Cho MK. "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening. Am J Med Genet A. 2016 Feb; 170A (2):363-374 Epub 2015 Nov 14
    View PubMed
76. Allyse M, Chandrasekharan S. Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond. Genet Med. 2015 Dec; 17 (12):958-61 Epub 2015 Mar 19
    View PubMed
77. Allyse M, Sayres LC, Michie M, Goodspeed T, Cho M. Don't want no risk, don't want no problems: Public understandings of the risks and benefits of novel prenatal technologies in the United States. AJOB Empirical Bioethics.2015;6:(1):5-20.
    View PubMed
78. Minear MA, Alessi S, Allyse M, Michie M, Chandrasekharan S. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues. Annu Rev Genomics Hum Genet. 2015; 16:369-98.
    View PubMed
79. Sayres LC, Allyse M, Goodspeed T, Cho MK. Demographic and Experiential Predictors of Public Attitudes towards Cell-Free Fetal DNA Journal of Genetic Counseling.0;23:(6):957-67.
    View PubMed
80. Chandresekharan S, Minear M, Hung A, Allyse M. Noninvasive prenatal testing goes global. Science Translational Medicine.2014;
    
81. Allyse M, Sayres LC, Goodspeed T, Cho MK. Attitudes Towards Non-Invasive Prenatal Testing Among US Adults of Reproductive Age Journal of Perinatology. 2014 March 6.
    
82. Allyse M, Minear M, Berson E, Rote M, Sidhar S, Hung A, Chandresekharan S. Non-Invasive Prenatal Testing: A review of international implementation and challenges International Journal of Women's Health. 2014.
    
83. Constantine M, Allyse M, Wall M, De Vries R, Rockwood TH. Imperfect Informed Consent in Non-Invasive Prenatal Testing: Lessons from the quad screen. Clinical Ethics.2013;
    
84. Berryessa C, Martinex-Martin N, Allyse M. Ethical, Legal and Social Issues Surrounding Research on Genetic Contributions to Anti-Social Behavior Aggression and Violent Behavior.2013;605-610.
    
85. Allyse M, Sayres LC, Havard M, Norton ME, Hudgins L, Taylor J, King JS, Cho MK, Greely HT, Magnus D, Ormond KE. Best Practices in the Provision of Non-Invasive Prenatal Diagnosis Prenatal Diagnosis. 2013:656-61.
    
86. Allyse M, Michie M. Not-so-incidental-findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing Trends in Biotechnology. 2013:439-41.
    
87. Allyse M. 23andMe, We and You: Direct-to-consumer genetics, intellectual property and informed consent Trends in Biotechnology. 2013:68-69.
    
88. Goodspeed T, Allyse M, Sayres L, Norton ME, Cho MK. Translating Cell-Free Fetal DNA Trends in Biotechnology.2013;7-9.
    
89. Allyse M, Sayres L, Norton M, King JS, Cho MK. Cell-free fetal DNA testing for fetal aneuploidy and beyond: Clinical integration challenges in the United States context Human Reproduction. 2012:3123-3131.
    
90. Sayres LC, Allyse M, Goodspeed T, Cho MK. In the public interest? Consequences of broad patenting and restrictive licensing for cell-free fetal DNA testing Science Translational Medicine.2012;
    
91. Sayres LC, Allyse M, Cho MK. Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy. Genome Medicine.2012;49.
    
92. Tobin SL, Cho MK, Lee SSJ, Magnus D, Allyse M, Ormond KE, Garrison N. Customers or Research Participants? Guidance for Research Practices in Commercialization of Personal Genomics Genetics in Medicine. 2012:833-835.
    
93. Allyse M, Karkazis K, Lee SSJ, Tobin SL, Greely HT, Cho MK, Magnus D. Informational Risk, Institutional Review, and Autonomy in the Proposed Changes to the Common Rule IRB: Ethics & Human Research. 2012.
    
94. Sayres LC, Allyse M, Norton ME, Cho MK. Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation Prenat Diagnosis.2011;1070-6.
    
95. Allyse M, Milner LC, Cho MK. Ethics watch: the G.I. genome: ethical implications of genome sequencing in the military Nature Reviews Genetics. 2011; Ethics watch:589.
    
96. Allyse M. Embryos, Ethics and Expertise: the emerging model of the scientific research ethics regulator Science and Public Policy. 2010:597-610.